JP2026507789A5 - - Google Patents

Info

Publication number
JP2026507789A5
JP2026507789A5 JP2025544829A JP2025544829A JP2026507789A5 JP 2026507789 A5 JP2026507789 A5 JP 2026507789A5 JP 2025544829 A JP2025544829 A JP 2025544829A JP 2025544829 A JP2025544829 A JP 2025544829A JP 2026507789 A5 JP2026507789 A5 JP 2026507789A5
Authority
JP
Japan
Prior art keywords
payload
linker
antibody
lys
terminus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025544829A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026507789A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2024/079076 external-priority patent/WO2025082990A1/en
Publication of JP2026507789A publication Critical patent/JP2026507789A/ja
Publication of JP2026507789A5 publication Critical patent/JP2026507789A5/ja
Pending legal-status Critical Current

Links

JP2025544829A 2023-10-15 2024-10-15 ２つの異なる種類のトポイソメラーゼｉ阻害剤を使用する抗体－薬物コンジュゲート Pending JP2026507789A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP23203677.2 2023-10-15
EP23203677 2023-10-15
EP24187879.2 2024-07-10
EP24187879 2024-07-10
EP24189861 2024-07-19
EP24189861.8 2024-07-19
PCT/EP2024/079076 WO2025082990A1 (en) 2023-10-15 2024-10-15 Antibody-drug conjugates using two different types of topoisomerase i inhibitors

Publications (2)

Publication Number Publication Date
JP2026507789A JP2026507789A (ja) 2026-03-06
JP2026507789A5 true JP2026507789A5 (cg-RX-API-DMAC10.html) 2026-04-22

Family

ID=98436133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025544829A Pending JP2026507789A (ja) 2023-10-15 2024-10-15 ２つの異なる種類のトポイソメラーゼｉ阻害剤を使用する抗体－薬物コンジュゲート

Country Status (8)

Country Link
US (1) US20260151498A1 (cg-RX-API-DMAC10.html)
EP (1) EP4731265A1 (cg-RX-API-DMAC10.html)
JP (1) JP2026507789A (cg-RX-API-DMAC10.html)
KR (1) KR20260052106A (cg-RX-API-DMAC10.html)
CN (1) CN121729250A (cg-RX-API-DMAC10.html)
AU (1) AU2024364674A1 (cg-RX-API-DMAC10.html)
IL (1) IL326369A (cg-RX-API-DMAC10.html)
MX (1) MX2026002619A (cg-RX-API-DMAC10.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240150807A (ko) * 2022-02-22 2024-10-16 아라리스 바이오테크 아게 2개 이상의 페이로드를 포함하는 펩티드 링커

Similar Documents

Publication Publication Date Title
AU2019320336B2 (en) Combination of antibody-drug conjugate and tubulin inhibitor
TWI822740B (zh) 抗her2雙互補位抗體-藥物結合物及使用方法
JP2025111463A5 (cg-RX-API-DMAC10.html)
HRP20230275T1 (hr) Antitijelo-lijek konjugati koji sadrže derivate ekteinascidina
JP2019520352A5 (cg-RX-API-DMAC10.html)
JP2022512830A5 (cg-RX-API-DMAC10.html)
JP2019528251A (ja) グリコシル化ｐｄ−ｌ１に結合する抗体の組合せを使用するがんの処置および治療の方法
JP2018520092A5 (cg-RX-API-DMAC10.html)
JP2020506971A5 (cg-RX-API-DMAC10.html)
JP2018520991A5 (cg-RX-API-DMAC10.html)
JP2019536740A5 (cg-RX-API-DMAC10.html)
JP2015524796A5 (ja) 細胞毒性剤と細胞結合受容体との共役体
JP2023515941A5 (cg-RX-API-DMAC10.html)
TW201925229A (zh) 經捲曲螺旋遮蔽之二價抗體
JP2007532139A5 (cg-RX-API-DMAC10.html)
RU2014124984A (ru) Конъюгаты антитело-лекарственное средство и родственные соединения, композиции и способы
JP2012522512A5 (cg-RX-API-DMAC10.html)
RU2015144098A (ru) Четырехвалентные биспецифические антитела
JP2018537975A5 (cg-RX-API-DMAC10.html)
RU2019129839A (ru) Производные майтанзиноида с саморасщепляющимися пептидными линкерами и их конъюгаты
CN114127117B (zh) 用于偶联的多肽复合物及其应用
JP2023546493A5 (cg-RX-API-DMAC10.html)
JP2023519776A5 (cg-RX-API-DMAC10.html)
JP2024523453A5 (cg-RX-API-DMAC10.html)
JP7720989B2 (ja) Ｅｇｆｒ及びｈｅｒ３を標的とする二重特異性四価抗体